Identification of approval conditions for orphan drugs for neurological disorders by the Japanese regulatory agency
Nakamura, Harumasa, Takeda, Shin’ichi, Iwasaki, MasaruVolume:
6
Language:
english
Journal:
Expert Opinion on Orphan Drugs
DOI:
10.1080/21678707.2018.1496013
Date:
July, 2018
File:
PDF, 1005 KB
english, 2018